| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $51,136,763 ) (Continued on the next page) |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01DE031756 | Regulation and Manipulation of Oral Type III Interferon Responses by Porphyromonas gingivalis | 001 | 4 | NIH | 4/16/2026 | $41,716 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01DE031756 | Regulation and Manipulation of Oral Type III Interferon Responses by Porphyromonas gingivalis | 000 | 4 | NIH | 12/4/2025 | $375,453 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R18HS030070 | Dissemination of a Facilitation Strategy to Deimplement Unnecessary Post-Operative Antibiotics at Children's Hospitals | 002 | 3 | AHRQ | 7/14/2026 | $400,000 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R18HS030070 | Dissemination of a Facilitation Strategy to Deimplement Unnecessary Post-Operative Antibiotics at Children's Hospitals | 001 | 3 | AHRQ | 5/11/2026 | -$400,000 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R18HS030070 | Dissemination of a Facilitation Strategy to Deimplement Unnecessary Post-Operative Antibiotics at Children's Hospitals | 000 | 3 | AHRQ | 4/21/2026 | $400,000 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HD116839 | A novel live biologic for the prevention and treatment of NEC-induced neurodevelopmental impairment | 000 | 3 | NIH | 5/28/2026 | $645,254 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL175924 | Mechanisms and Therapeutics for Congenital Aortic Valve Disease | 000 | 3 | NIH | 4/17/2026 | $651,528 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01AI175004 | Decipher and target GABA metabolism and GABA receptor-mediated signaling in autoimmune diseases | 000 | 4 | NIH | 1/9/2026 | $498,589 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01CA284073 | Adaptation and implementation of a web-based Family centered Adolescent Sperm banking decision Tool for adolescent males with cancer | 000 | 4 | NIH | 6/18/2026 | $365,597 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | UH3HL161338 | 1/2 percutaneous intervention versus observational trial of arterial ductus in lower gestational age infants (PIVOTAL) | 000 | 5 | NIH | 3/4/2026 | $418,217 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01DA058303 | Impact of Recreational and Medical Marijuana legalization on cannabis use disorders, serious mental illness, and mortality outcomes among Medicaid enrolled youth | 000 | 4 | NIH | 7/20/2026 | $566,893 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | F31HD113330 | A HUMAN IPSC-BASED ORGANOID PLATFORM FOR STUDYING MATERNAL HYPERGLYCEMIA-INDUCED CONGENITAL HEART DEFECTS | 001 | 3 | NIH | 4/1/2026 | $576 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | F31HD113330 | A HUMAN IPSC-BASED ORGANOID PLATFORM FOR STUDYING MATERNAL HYPERGLYCEMIA-INDUCED CONGENITAL HEART DEFECTS | 000 | 3 | NIH | 1/22/2026 | $43,138 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01DK138101 | Targeting Tubular Mitochondrial Superoxide Dismutation in Cisplatin Renal Repair | 000 | 3 | NIH | 7/1/2026 | $621,810 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01AI185926 | Viral Determinants of Chronic Hepacivirus Infection | 000 | 3 | NIH | 4/29/2026 | $665,540 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01AI181261 | Adaptive Immune Responses to Congenital and Postnatal Cytomegalovirus Infection | 000 | 2 | NIH | 4/28/2026 | $602,116 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01CA260178 | Targeting cooperative mechanisms of metastatic colonization in osteosarcoma | 000 | 5 | NIH | 6/26/2026 | $372,261 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HD107280 | Poly-Matching Causal Inference for Assessing Multiple Acute Medical Managements of Pediatric Traumatic Brain Injuries | 001 | 4 | NIH | 4/2/2026 | $54,851 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HD107280 | Poly-Matching Causal Inference for Assessing Multiple Acute Medical Managements of Pediatric Traumatic Brain Injuries | 000 | 4 | NIH | 1/23/2026 | $493,665 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01AI175800 | Role of antibodies in hepatitis E virus infection | 000 | 4 | NIH | 4/7/2026 | $822,317 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL165124 | The Role of Notch Signaling in Type 2 Diabetic Coronary Microvascular Disease | 001 | 4 | NIH | 3/26/2026 | $18,251 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL165124 | The Role of Notch Signaling in Type 2 Diabetic Coronary Microvascular Disease | 000 | 4 | NIH | 3/10/2026 | $577,986 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01NR020423 | Establishing Efficacy for the Congenital Heart Disease Physical Activity Lifestyle Intervention | 000 | 5 | NIH | 6/18/2026 | $572,943 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | T32HL166149 | Integrative Research Training Program in Pediatric Cardiopulmonary Disease | 000 | 4 | NIH | 5/7/2026 | $359,952 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | T32CA269052 | Training Program in Basic and Translational Pediatric Oncology Research | 000 | 5 | NIH | 4/6/2026 | $363,018 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | H4953004 | Healthy Start Initiative | 01 | 3 | HRSA | 5/20/2026 | $631,885 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | H4953004 | Healthy Start Initiative | 00 | 3 | HRSA | 4/2/2026 | $140,658 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | K23HL159312 | The Development and Evaluation of Visual Communication Tools to Convey Parental and Intergenerational Cardiovascular Disease Risk and Evoke Lifestyle Behavior Change | 000 | 5 | NIH | 6/26/2026 | $157,920 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HD109000 | Targeted Investment and Meaningful Engagement to Improve MCH Outcomes and Rectify Historical Structural Racism: The TIME Study | 000 | 5 | NIH | 6/21/2026 | $100,000 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HD109000 | Targeted Investment and Meaningful Engagement to Improve MCH Outcomes and Rectify Historical Structural Racism: The TIME Study | 000 | 5 | NIH | 6/21/2026 | $530,763 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R21CA309321 | MedMemos: A Program to Promote Medication Adherence in Pediatric Hematopoeitic Stem Cell Transplantation | 000 | 1 | NIH | 5/1/2026 | $406,258 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01CA299046 | Genetically and metabolically defining high-risk neuroblastoma to exploit effective therapeutic strategies | 000 | 1 | NIH | 4/2/2026 | $608,558 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | H7624736 | Ryan White Part C Outpatient EIS Program | 02 | 15 | HRSA | 6/24/2026 | $0 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | H7624736 | Ryan White Part C Outpatient EIS Program | 01 | 15 | HRSA | 5/11/2026 | $351,902 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | H7624736 | Ryan White Part C Outpatient EIS Program | 00 | 15 | HRSA | 3/31/2026 | $75,556 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL179812 | Novel pathogenesis of LVNC | 000 | 2 | NIH | 4/2/2026 | $669,388 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R03DK140423 | Defining Stat3 Antimicrobial Mechanisms in Human Urothelium | 000 | 2 | NIH | 5/12/2026 | $117,000 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | K08NS119878 | Reversal of Immunoparalysis Following Traumatic Brain Injury and Systemic Hemorrhage in a Juvenile Rat Model | 000 | 5 | NIH | 4/27/2026 | $187,635 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | U24CA254445 | EET Biobank Funding for 2026-2027 | 001 | 6 | NIH | 7/14/2026 | $2,110,316 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL148171 | Strategies to correct defective CF macrophage--mediated bacterial killing | 001 | 6 | NIH | 7/17/2026 | $761,274 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01CA248103 | Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects | 001 | 6 | NIH | 4/16/2026 | $54,436 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01CA248103 | Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects | 000 | 6 | NIH | 1/30/2026 | $489,921 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01DK115737 | The Contributions of Ribonuclease 4 & 7 to Urinary Tract Antibacterial Defense | 000 | 6 | NIH | 6/16/2026 | $685,156 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | K08CA290060 | A digital health parent coaching intervention to improve neurodevelopmental outcomes for young childhood cancer survivors in underserved communities | 000 | 2 | NIH | 2/27/2026 | $185,795 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL176685 | Role of cardiac m6A methyltransferases | 001 | 2 | NIH | 5/1/2026 | $22,329 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL176685 | Role of cardiac m6A methyltransferases | 000 | 2 | NIH | 3/20/2026 | $707,045 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01NS129784 | Deciphering brain mosaicism in drug-resistant epilepsy at cellular resolution | 001 | 4 | NIH | 2/28/2026 | $54,401 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01NS129784 | Deciphering brain mosaicism in drug-resistant epilepsy at cellular resolution | 000 | 4 | NIH | 1/31/2026 | $489,615 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01AI183877 | Animal Model to study heterogeneous outcomes of HCV Infection and Pathogenesis | 000 | 3 | NIH | 4/29/2026 | $780,961 |
|
